Switzerland· 63023006

Elvanse

A lisdexamfetamine product containing lisdexamfetamini dimesilas, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC N06BA12

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedElvanseATCN06BA12REGISTER NO.63023006PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Lisdexamfetamine is registered in 15 of 19 countries.

Countries holding a registration under ATC N06BA12 (lisdexamfetamine), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Lisdexamfetamine · ATC N06BA12

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lisdexamfetamine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • Switzerland: $3.28 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Lisdexamfetamine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
lisdexamfetamini dimesilas
Manufacturer
—
Country
Switzerland (CH)
ATC code
N06BA12
ATC class
Lisdexamfetamine
Defined daily dose
30 mg, O
Swissmedic category
A
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680630230065
    30 Stk
    CHF 133

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

217 interactions on record for lisdexamfetamine.

Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lisdexamfetamine · interactions on record

217 records

  • 51 severe
  • 164 moderate
  • 2 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • FenfluramineA08AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lisdexamfetamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lisdexamfetamine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Elvanse, Elvanse Erwachsene
  • Belgium · Elvanse
  • Czechia · Livizux
  • Germany · Elvanse, Lisdex- Aristo
  • Denmark · Adixemin, Aduvanz
  • Estonia · Adixemin, Elvanse
  • Spain · Elvanse, Elvanse Adultos
  • Finland · Dexhility, Elvanse
  • France · Fobettin, Xurta
  • United Kingdom (Northern Ireland) · Elvanse, Elvanse Adult
  • Hungary · Livizux
  • Ireland · Lisdexamfetamine Dimesylate Rowex, Tyvense
  • Iceland · Amdex, Dexhility
  • Italy · Minalix
  • Lithuania · Adixemin
  • Luxembourg · Elvanse
  • Latvia · Adixemin, Lisdexamfetamine Zentiva
  • Malta · Lisdexamfetamin, Lisdexamfetamine Aristo Aristo
  • Netherlands · Elvanse, Lisdexamfetamine Aristo Aristo
  • Norway · Aduvanz, Balidax
  • Poland · Eldefab, Elvanse
  • Portugal · Dimesilato De Lisdexanfetamina Teva, Dimesilato De Lisdexanfetamina Zentiva
  • Romania · Lisdexamfetaminä Stada
  • Sweden · Balidax, Dexhility
  • Slovenia · Lisdeksamfetamin Aristo, Lisdeksamfetamin Aristo Aristo
  • Slovakia · Livizux

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b3633e24-80e3-475a-9f8f-caa6bdb5ff8a
GET /v1/drugs/b3633e24-80e3-475a-9f8f-caa6bdb5ff8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "lisdexamfetamini dimesilas 60 mg",
  "valid_from": "2017-07-01",
  "limitations": "[{\"description\":\"Kinder und Jugendliche:<br>\\nNur zur second-line Behandlung des ADHS, d.h. bei Unverträglichkeit, Kontraindikation oder nicht Ansprechen von Methylphenidat im Rahmen einer therapeutischen Gesamtstrategie. Wenn Patienten über 1 Jahr hinaus behandelt werden, so hat eine erneute Überprüfung der Behandlungsnotwendigkeit durch einen Facharzt der Psychiatrie und Psychotherapie oder Pädiatrie mit Spezialisierung auf Behandlung des ADHS zu erfolgen.<br>\\nErwachsene:<br>\\nNur zur second-line Behandlung des ADHS, d.h. bei Unverträglichkeit, Kontraindikation oder nicht Ansprechen von Methylphenidat im Rahmen einer therapeutischen Gesamtstrategie. Die Diagnosestellung und initiale Verordnung hat durch einen Facharzt der Psychiatrie und Psychotherapie oder Pädiatrie mit Spezialisierung auf Behandlung des ADHS zu erfolgen. Die Diagnose hat anhand der Kriterien resp. Richtlinien der Fachinformation zu erfolgen. Bei Erwachsenen müssen entsprechende Symptome bereits in der Kindheit bestanden haben. Wenn Patienten über 1 Jahr hinaus behandelt werden, so hat eine erneute Überprüfung der Behandlungsnotwendigkeit durch einen Facharzt der Psychiatrie und Psychotherapie oder Pädiatrie mit Spezialisierung auf Behandlung des ADHS zu erfolgen.\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2017-07-01\",\"validTo\":null}]",
  "galenic_form": "Kaps 60 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2017-07-01",
  "self_retention_pct": 10
}

See everything about lisdexamfetamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.